Concepedia

M-L Dahl

MD

8

Publications

870

Citations

8

H-Index

1994

Active since

Affiliations

Karolinska Institutet(Current)

Karolinska University Hospital

Uppsala University

Uppsala University Hospital

M-L Dahl is an author at Karolinska Institutet specializing in medicine, hematology, and pharmacology.

Top concepts

Publications per year

1994–2012

8

Publications

8

Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test.

Leif Bertilsson, JA Carrillo, M-L Dahl et al. · British Journal of Clinical Pharmacology · 1994 · 306 citations · Full text

Interphenotype differences in disposition and effect on gastrin levels of omeprazole—suitability of omeprazole as a probe for CYP2C19.

Ming Chang, Gunnel Tybring, M-L Dahl et al. · British Journal of Clinical Pharmacology · 1995 · 184 citations · Full text

A PK–PD Model for Predicting the Impact of Age, CYP2C9, and VKORC1 Genotype on Individualization of Warfarin Therapy

Anna‐Karin Hamberg, M-L Dahl, Martina Barban et al. · Clinical Pharmacology & Therapeutics · 2007 · 142 citations

, , +21

Pharmacodynamics of Carbamazepine-mediated Induction of CYP3A4, CYP1A2, and Pgp as Assessed by Probe Substrates Midazolam, Caffeine, and Digoxin

M-L Dahl, Jonas Cederberg, MO Karlsson et al. · Clinical Pharmacology & Therapeutics · 2007 · 94 citations

Patterns of drug treatment of schizophrenic patients in Estonia, Spain and Sweden.

R A Kiivet, Adrián LLerena, M-L Dahl et al. · British Journal of Clinical Pharmacology · 1995 · 59 citations · Full text

Rows per page

1–5 of 8